Avanos Medical Inc (AVNS)
Pretax margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | -59,800 | 65,200 | 7,300 | -62,900 | -64,000 |
| Revenue | US$ in thousands | 587,500 | 810,000 | 741,300 | 699,300 | 682,600 |
| Pretax margin | -10.18% | 8.05% | 0.98% | -8.99% | -9.38% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $-59,800K ÷ $587,500K
= -10.18%
The pretax margin of Avanos Medical Inc has fluctuated over the past five years, with negative values recorded in 2020 at -8.46% and in 2019 at -9.17%. The margin improved significantly in 2022, reaching 7.95%, indicating a period of stronger profitability. However, this positive trend did not continue in 2023 as the pretax margin decreased to -1.17%. This decline suggests a reduction in the company's profitability before accounting for taxes in the most recent fiscal year. Overall, the company's pretax margin performance has been volatile, emphasizing the importance of closely monitoring and addressing factors affecting profitability.
Peer comparison
Dec 31, 2023